AMICAR (Clover Pharmaceuticals Corp.)


Welcome to the PulseAid listing for the AMICAR drug offered from Clover Pharmaceuticals Corp.. This Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Clover Pharmaceuticals Corp.
NON-PROPRIETARY NAME: Aminocaproic Acid
SUBSTANCE NAME: AMINOCAPROIC ACID
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE]
ROUTE: ORAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-06-01
END MARKETING DATE: 0000-00-00


AMICAR HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAMICAR from Clover Pharmaceuticals Corp.
LABELER NAME: Clover Pharmaceuticals Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.25(g/mL)
START MARKETING DATE: 2015-06-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49411-052_bba3bfb1-b56e-4370-8b68-25f18db3fc02
PRODUCT NDC: 49411-052
APPLICATION NUMBER: NDA015230

Other AMINOCAPROIC ACID Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.Aminocaproic Acid
Avera McKennan HospitalAMICAR
Clover Pharmaceuticals Corp.AMICAR
Hospira, Inc.Aminocaproic Acid
VersaPharm IncorporatedAminocaproic Acid